The Hill: President Trump’s health secretary pushed back Monday at critics who said Trump’s drug pricing plan moved away from his campaign pledge of having Medicare negotiate drug prices.
Health and Human Services (HHS) Secretary Alex Azar dismissed the idea — backed by many Democrats — that Medicare can save money by negotiating directly with drug companies.
“The only way that direct negotiation saves money is by doing something this administration does not believe in: denying access to certain medicines for all Medicare beneficiaries, or setting prices for drugs by government fiat,” Azar said in a speech at HHS headquarters.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now